IBRX Latest Headlines

FDA, Duke-Margolis workshop to examine evidence standards for rare diseases

at seekingalpha.com (Sun, 20-Sep 2:57 PM)

ImmunityBio’s Revenue Jump and Global Expansion Highlight a Turning Point Despite Steep Losses

Market Chameleon (Tue, 4-Aug 7:42 AM)

UAE Leads with World’s Broadest ANKTIVA Approval: ImmunityBio Gains Crucial Bladder and Lung Cancer Clearances

Market Chameleon (Thu, 30-Jul 7:08 AM)